GPX4 and neoplasm: On the contrary, it has also been suggested that inhibition of HSP90 can forcibly deplete glutathione (GSH) in tumor cells to weaken the antioxidant capacity of the cells, increase ROS content, decrease GPX4 expression, and therefore accelerate ferroptosis [35].